Hubei Biocause Heilen Pharmaceutical Dividend
Dividend criteria checks 3/6
Hubei Biocause Heilen Pharmaceutical is a dividend paying company with a current yield of 3.26% that is well covered by earnings.
Key information
3.3%
Dividend yield
80%
Payout ratio
| Industry average yield | 1.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | CN¥0.60 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 301211 has been paying a dividend for less than 10 years.
Growing Dividend: 301211's dividend payments have increased, but the company has only paid a dividend for 2 years.
Dividend Yield vs Market
| Hubei Biocause Heilen Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (301211) | 3.3% |
| Market Bottom 25% (CN) | 0.7% |
| Market Top 25% (CN) | 2.6% |
| Industry Average (Pharmaceuticals) | 1.9% |
| Analyst forecast in 3 Years (301211) | n/a |
Notable Dividend: 301211's dividend (3.26%) is higher than the bottom 25% of dividend payers in the CN market (0.71%).
High Dividend: 301211's dividend (3.26%) is in the top 25% of dividend payers in the CN market (2.56%)
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (80%), 301211's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 301211 is paying a dividend but the company has no free cash flows.